Journals / ANKEM Dergisi / 2011 / Cilt: 25 - Sayı: 3

Evaluation of 133 patients with acute pyelonephritis

Akut piyelonefritli 133 hastanın değerlendirilmesi

Pages
157–163
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In conclusion, APN is a common clinical entity and cases should be evaluated in terms of complicating factors.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Acute pyelonephritis (APN) is bacterial or fungal infection of the urinary tract or renal parenchyma.
📊
Key Findings & Data:In this study, patients followed up between January 2003 and March 2011 with pyelonephritis were evaluated for laboratory findings, complicating factors and clinical outcome.
💡
Conclusion & Impact:In conclusion, APN is a common clinical entity and cases should be evaluated in terms of complicating factors.
🔬Design:Research Article
📍Scope:2003 Verileri
⚙️Variables:Domain Parameters

Abstract

Acute pyelonephritis (APN) is bacterial or fungal infection of the urinary tract or renal parenchyma. In this study, patients followed up between January 2003 and March 2011 with pyelonephritis were evaluated for laboratory findings, complicating factors and clinical outcome. During the study period there were 133 patients diagnosed with acute pyelonephritis (38 % male, 62 % female, aged 48.8±18.7 years). Seventy-two patients (54 %) had their first APN attack whereas 61 patients had their second or more episodes. There were no complicating factors in 25 % of patients however 16 % of patients had more than one complicating factor, and urinary catheterisation and obstructive uropathy were the most common complicating factors. In this series, complicating factors were detected by ultrasonography in 45 patients (34 %) who did not have such a medical history. In conclusion, APN is a common clinical entity and cases should be evaluated in terms of complicating factors.

Özet

Akut piyelonefrit (APN), renal parankim ve toplayıcı sistemin bakteriyel veya fungal infeksiyonudur. Bu çalışmada, Ocak 2003-Mart 2011 tarihleri arasında kliniğimizde takip edilen APN olguları; komplike edici faktörler, klinik gidiş ve laboratuvar bulguları yönlerinden değerlendirilmiştir. Çalışma süresince 133 hastaya APN tanısı konmuştur (% 38 erkek, % 62 kadın, yaş ortalamaları 48.8±18.7 yıl). Yetmiş iki hasta (% 54) ilk kez APN geçirirken 61 hasta (% 46) yaşamları boyunca ortalama iki ve daha fazla APN atağı geçirmiştir. Hastaların % 25’inde komplike edici faktör saptanmazken; hastaların % 16’sında birden fazla komplike edici faktör bulunmuştur. En sık komplike edici faktörler obstrüktif üropati ve üriner kateterizasyon olarak belirlenmiştir. Bu çalışmada öyküsünde komplike edici faktör bulunmayan 45 (% 34) hastada batın ultrasonografisinde komplike edici faktör saptanmıştır. Sonuç olarak APN sık bir klinik durum olup, olgular olası komplike edici faktörler açısından değerlendirilmelidir.

🔖

Cite This Article

IŞIKGÖZ, M. T., ŞENOL, Ş., ŞİMŞİR, A., PULLUKÇU, H., KAHRAMAN, H., SİPAHİ, O. R., YAMAZHAN, T., ARDA, B., KISMALI, E., TÜNGER, A., ULUSOY, S. (2011). Evaluation of 133 patients with acute pyelonephritis. ANKEM Dergisi, Cilt: 25 - Sayı: 3, 157–163. https://ajindex.com/articles/355058

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. Fourteenth - Sixteenth Informational Supplement (M100-S16), CLSI, Wayne, PA (2004-2006)
  2. Czaja CA, Scholes D, Hooton TM, Stamm WE. Population based epidemiologic analysis of acute pyelonephritis, Clin Infect Dis 2007;45(3):273-80. http://dx.doi.org/10.1086/519268 PMid:17599303 3. Doyuk KE, Ünlü F, Nayman AS, Özgüneş İ, Usluer G. Kliniğimizde izlenen komplike üst üriner sistem infeksiyonları, Flora 2006;11(4):181-7
  3. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs, Am J Med 2002;113(1):5-13.
  4. Foxman B, Klemstine KL, Brown PD. Acute pyelonephritis in US hospitals in 1997: hospitalization and in-hospital mortality, Ann Epidemiol 2003;13(2):144-50.
  5. Hooton TM, Bradley SF, Cardenas DD et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America, Clin Infect Dis 2010;50(5):625-63. http://dx.doi.org/10.1086/650482 PMid:20175247 7. Karakeçili F, Karadağ S, Erbay F. Pyelonefrit: 190 olgunun retrospektif analizi, Klimik Derg 2010; 23(1):10-4
  6. Klausner HA, Brown P, Peterson J et al. A trial of levofloxacin 750 mg once daily for 5 days versus ciprofloxacin 400 mg and/or 500 mg twice daily for 10 days in the treatment of acute pyelonephritis, Curr Med Res Opin 2007;23(11):2637-45. http://dx.doi.org/10.1185/030079907X233340 PMid:17880755 9. Naber KG, Llorens L, Kaniga K, Kotey P, Hedrich D, Redman R. Intravenous doripenem at 500 milligrams versus levofloxacin at 250 milligrams, with an option to switch to oral therapy, for treatment of complicated lower urinary tract infection and pyelonephritis, Antimicrob Agents Chemother 2009;53(9):3782-92. http://dx.doi.org/10.1128/AAC.00837-08 PMid:19581455 PMCid:2737884 10. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing. 11th Informational Supplement. Document M100-S10, Vol. 21 No. 1, NCCLS, Wayne, PA (2001)
  7. Nicolle LE, Friesen D, Harding GK, Roos LL. Hospitalization for acute pyelonephritis in Manitoba, Canada, during the period from 1989 to 1992; impact of diabetes, pregnancy, and aboriginal origin, Clin Infect Dis 1996;22(6):1051-6. http://dx.doi.org/10.1093/c